Mood Disorders
Major Depressive Disorder (MDD)
Prevalence ~8% adultsF > M 2:1DSM-5 Criteria
โฅ5 symptoms for โฅ2 weeks, one of which is depressed mood OR anhedonia. Remember SIG-E-CAPS:
- Sleep disturbance (insomnia or hypersomnia)
- Interest / pleasure loss (anhedonia)
- Guilt / worthlessness
- Energy loss / fatigue
- Concentration impaired
- Appetite / weight change
- Psychomotor agitation or retardation
- Suicidal ideation
Specifiers
- With melancholic features โ severe anhedonia, diurnal variation (worse AM), early awakening, psychomotor changes, weight loss, guilt
- With atypical features โ mood reactivity, hypersomnia, hyperphagia, leaden paralysis, rejection sensitivity (responds best to MAOIs historically)
- With psychotic features โ mood-congruent delusions (guilt, poverty, nihilism); needs antipsychotic + antidepressant or ECT
- With peripartum onset โ during pregnancy or within 4 weeks postpartum
- With seasonal pattern โ light therapy 10,000 lux first-line
Workup (rule out medical causes)
- CBC, CMP, TSH, B12/folate, vitamin D
- Urine drug screen, RPR if risk factors
- PHQ-9 (โฅ10 moderate, โฅ15 severe, โฅ20 very severe)
- Always screen suicidality (C-SSRS)
Bipolar Disorder
Type I vs II
| Type | Mania | Hypomania | Depression |
|---|---|---|---|
| Bipolar I | โฅ1 manic episode (โฅ7 days or hospitalized) | โ | Usually present, not required |
| Bipolar II | Never | โฅ1 hypomanic (โฅ4 days) | โฅ1 major depressive episode required |
| Cyclothymic | Subthreshold up & down for โฅ2 yr | โ | โ |
Mania Criteria โ DIG FAST
- Distractibility
- Impulsivity / Indiscretion
- Grandiosity
- Flight of ideas
- Activity increased (goal-directed)
- Sleep โ (without fatigue)
- Talkativeness / pressured speech
Persistent Depressive Disorder (Dysthymia)
Depressed mood most days for โฅ2 years (โฅ1 yr in children), with โฅ2 other symptoms. Chronic, lower-grade โ but high comorbidity with MDD ("double depression").
Anxiety Disorders
Generalized Anxiety Disorder (GAD)
Excessive worry about multiple events, difficult to control, โฅ6 months, with โฅ3 somatic symptoms (in adults): restlessness, fatigue, โ concentration, irritability, muscle tension, sleep disturbance.
Tx: CBT + SSRI or SNRI (duloxetine, venlafaxine). Buspirone is adjunct. Benzos short-term only.
Panic Disorder
Recurrent unexpected panic attacks + โฅ1 month of worry about future attacks or behavioral change (avoidance).
Panic Attack Criteria
Abrupt surge of intense fear peaking within minutes, with โฅ4 of: palpitations, sweating, trembling, SOB, choking sensation, chest pain, nausea, dizziness, chills/heat, paresthesias, derealization, fear of losing control, fear of dying.
Tx: CBT (panic-focused) + SSRI/SNRI. Benzo bridge during SSRI titration for severe.
Specific Phobia
Marked fear of a specific object/situation (animals, heights, blood-injection-injury, situational). Exposure therapy is definitive treatment.
OCD & Related Disorders
| Disorder | Hallmark |
|---|---|
| OCD | Obsessions + compulsions, โฅ1 hr/day |
| Body Dysmorphic Disorder | Preoccupation with perceived physical defect |
| Hoarding Disorder | Persistent difficulty discarding possessions |
| Trichotillomania | Recurrent hair-pulling |
| Excoriation | Skin-picking disorder |
Tx: CBT with Exposure & Response Prevention (ERP) is first-line. SSRIs (often high-dose โ fluoxetine 60โ80 mg, sertraline 200 mg) or clomipramine second-line. N-acetylcysteine has evidence for trichotillomania.
Trauma- and Stressor-Related Disorders
PTSD Criteria (DSM-5, โฅ1 month)
- Exposure to actual/threatened death, serious injury, or sexual violence
- Intrusion โ flashbacks, nightmares, intrusive memories
- Avoidance โ of trauma-related stimuli
- Negative cognition / mood โ shame, estrangement, anhedonia
- Hyperarousal โ hypervigilance, startle, irritability, sleep disturbance
| Duration | Diagnosis |
|---|---|
| < 3 days | Acute stress reaction (normal) |
| 3 days โ 1 month | Acute Stress Disorder |
| > 1 month | PTSD |
| After stressor, < 3 months onset, doesn't meet full criteria | Adjustment Disorder |
Treatment
- First-line psychotherapy: Trauma-focused CBT, Prolonged Exposure, EMDR, CPT
- First-line meds: SSRIs (sertraline and paroxetine are FDA-approved), venlafaxine
- Prazosin for nightmares (ฮฑ1 antagonist)
- Avoid: benzodiazepines (worsen long-term outcome, โ dependence risk)
Psychotic Disorders
Duration-Based Classification
| Duration | Diagnosis |
|---|---|
| < 1 month | Brief Psychotic Disorder |
| 1โ6 months | Schizophreniform |
| > 6 months | Schizophrenia |
| Psychotic + mood episodes; psychotic sx for โฅ2 wk WITHOUT mood sx | Schizoaffective |
| Nonbizarre delusions, โฅ1 month, function preserved | Delusional Disorder |
Schizophrenia โ Symptom Domains
- Positive: hallucinations (auditory most common), delusions, disorganized speech/behavior
- Negative: affective flattening, alogia, avolition, anhedonia, asociality (5 A's)
- Cognitive: working memory, executive deficits
- Mood: depression, suicidality (lifetime suicide risk ~5%)
Key Epidemiology
- Onset: late teens to mid-20s (M); 20sโ30s (F)
- M = F incidence; worse prognosis in M
- Genetic: ~50% concordance in monozygotic twins; ~10% if one first-degree relative
Personality Disorders
Enduring pattern of inner experience and behavior deviating from cultural expectation, pervasive, inflexible, onset in adolescence/early adulthood, causing distress/impairment.
| Cluster | Theme | Disorders |
|---|---|---|
| A โ "Weird" | Odd, eccentric | Paranoid, Schizoid, Schizotypal |
| B โ "Wild" | Dramatic, erratic | Antisocial, Borderline, Histrionic, Narcissistic |
| C โ "Worried" | Anxious, fearful | Avoidant, Dependent, Obsessive-Compulsive PD |
Highest-Yield Features
- Borderline: splitting, identity disturbance, fear of abandonment, self-harm, chronic emptiness. Tx: DBT (dialectical behavior therapy) โ gold standard.
- Antisocial: โฅ18 yr, hx of conduct disorder before 15; disregard for others' rights
- Narcissistic: grandiosity, need for admiration, lack of empathy
- OCPD (different from OCD): perfectionism, rigidity, control โ ego-syntonic (patient doesn't mind); OCD is ego-dystonic
Somatic Symptom & Related Disorders
| Disorder | Feature |
|---|---|
| Somatic Symptom Disorder | Excessive thoughts/feelings about somatic symptoms โฅ6 mo |
| Illness Anxiety Disorder | Preoccupation with having illness despite few/no symptoms |
| Functional Neurologic (Conversion) | Neuro sx incompatible with disease; often after stressor |
| Factitious Disorder | Intentional fabrication/induction for sick role (no external gain) |
| Malingering | Intentional fabrication for external gain (not a psych disorder) |
Dissociative Disorders
- Dissociative Amnesia โ inability to recall autobiographical info, usually trauma-related
- Dissociative Identity Disorder (DID) โ โฅ2 distinct personality states; usually severe childhood trauma
- Depersonalization / Derealization โ persistent sense of detachment from self or surroundings
Substance Use Disorders
DSM-5 uses 11 criteria across 4 groups (impaired control, social impairment, risky use, pharmacologic โ tolerance/withdrawal). Severity: mild 2โ3, moderate 4โ5, severe โฅ6 criteria in 12 months.
| Substance | Intoxication | Withdrawal | Tx |
|---|---|---|---|
| Alcohol | Disinhibition, slurred speech, ataxia | Tremor โ seizure (24โ48 h) โ DTs (48โ96 h, ~15% mortality untreated) | Benzos (taper), thiamine BEFORE glucose; naltrexone, acamprosate, disulfiram |
| Opioids | Pinpoint pupils, respiratory depression, euphoria | Piloerection, rhinorrhea, myalgia, diarrhea โ uncomfortable NOT dangerous | Naloxone (acute); buprenorphine, methadone, naltrexone for MOUD |
| Stimulants (cocaine, meth) | Mydriasis, HTN, agitation, hyperthermia, psychosis | Dysphoria, hypersomnia, hyperphagia, craving | Supportive; benzos for agitation |
| Cannabis | Red eyes, dry mouth, โ appetite, impaired memory | Irritability, insomnia, dysphoria | CBT, motivational interviewing |
| Benzodiazepines | Sedation, ataxia, resp depression (esp w/ alcohol/opioids) | Like alcohol: tremor, seizure, death possible | Slow taper; flumazenil (risky โ can cause seizure) |
| Hallucinogens (LSD, psilocybin) | Perceptual changes, mydriasis, โ HR/BP | None significant | Supportive, "talk down," benzo for agitation |
| PCP | Vertical/horizontal nystagmus, violence, analgesia | None significant | Benzos, antipsychotics, safety |
Psychiatric Emergencies
Suicide Risk Factors โ "SAD PERSONS"
- Sex (male)
- Age (<19 or >45)
- Depression
- Previous attempt
- Ethanol/substance use
- Rational thinking loss (psychosis)
- Social support lacking
- Organized plan
- No spouse / single
- Sickness (chronic illness)
Most completed suicides: men, older adults, firearms. Always ask directly โ asking does NOT increase risk.
Neuroleptic Malignant Syndrome (NMS)
Idiosyncratic reaction to D2 blockade. Tetrad: "FEVER" โ Fever (hyperthermia), Encephalopathy, Vitals unstable, Enzyme โ (CK), Rigidity ("lead pipe").
Tx: Stop antipsychotic, aggressive cooling & IVF, dantrolene, bromocriptine; ICU.
Serotonin Syndrome vs NMS
| Feature | Serotonin Syndrome | NMS |
|---|---|---|
| Onset | Hours | Daysโweeks |
| Reflexes | Hyperreflexia, clonus | Bradyreflexia, rigidity (lead-pipe) |
| Pupils | Mydriasis | Normal |
| Trigger | Serotonergic drug | D2 antagonist (or rapid levodopa withdrawal) |
| Tx | Cyproheptadine, supportive | Dantrolene, bromocriptine, supportive |
Lithium Toxicity
Narrow therapeutic index (0.6โ1.2 mEq/L). Toxicity: coarse tremor, ataxia, confusion, seizures, nephrogenic DI. Triggers: dehydration, NSAIDs, ACEIs, thiazides. Hemodialysis if level > 4.0 or severe symptoms.
Social Anxiety Disorder
Marked fear of social/performance situations, exposure provokes anxiety, avoidance, โฅ6 months. Tx: CBT + SSRI; ฮฒ-blocker (propranolol 10โ40 mg) for performance-only subtype.